Fulgent Genetics, Inc. FLGT Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization?
- Fulgent Genetics, Inc. (FLGT) reported operating lease right-of-use asset amortization of $352K in Q1 2026.
- How has Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization increased by 0.6% year-over-year, from $350K to $352K.
- What is the long-term trend for Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization?
- Over 2 years (2022 to 2025), Fulgent Genetics, Inc.'s operating lease right-of-use asset amortization has grown at a -40.1% compound annual growth rate (CAGR), from $4.91M to $1.76M.